Coagulation Factor Xa: The Prothrombinase Complex as an Emerging Therapeutic Target for Small Molecule Inhibitors
- 1 January 1998
- journal article
- other
- Published by Taylor & Francis in Journal of Enzyme Inhibition
- Vol. 14 (1) , 15-25
- https://doi.org/10.3109/14756369809036543
Abstract
(1998). Coagulation Factor Xa: The Prothrombinase Complex as an Emerging Therapeutic Target for Small Molecule Inhibitors. Journal of Enzyme Inhibition: Vol. 14, No. 1, pp. 15-25.Keywords
This publication has 20 references indexed in Scilit:
- Identification and Initial Structure−Activity Relationships of a Novel Class of Nonpeptide Inhibitors of Blood Coagulation Factor XaJournal of Medicinal Chemistry, 1998
- Discovery of a Novel, Potent, and Specific Family of Factor Xa Inhibitors via Combinatorial ChemistryBiochemistry, 1998
- Rational Design and Synthesis of Novel, Potent Bis-phenylamidine Carboxylate Factor Xa InhibitorsJournal of Medicinal Chemistry, 1998
- Small-molecule direct thrombin inhibitorsExpert Opinion on Therapeutic Patents, 1997
- Bisbenzamidine isoxazoline derivatives as factor Xa inhibitorsBioorganic & Medicinal Chemistry Letters, 1997
- X-ray Structure of Active Site-inhibited Clotting Factor XaPublished by Elsevier ,1996
- Proposed cation‐π mediated binding by factor Xa: a novel enzymatic mechanism for molecular recognitionFEBS Letters, 1995
- Intracranial bleeding, fibrinolysis, and anticoagulation. Causal connections and clinical implications.Circulation, 1994
- Dibasic (Amidinoaryl)propanoic Acid Derivatives as Novel Blood Coagulation Factor Xa InhibitorsJournal of Medicinal Chemistry, 1994
- Selective factor Xa inhibition by recombinant antistasin prevents vascular graft thrombosis in baboons.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992